Categorías
- Instrumentos
- Agitadores / Agit. Incubadores
- Orbitales
- Con Incubación
- Incubadores Gran Capacidad
- Lineales, Balanceo y 3D
- Incubadores Microplacas
- Para colocar en estufa
- Magnéticos
- Mezcladores /Roller /Rotatorios
- Agitadores de Paletas
- Jeio Tech Accesorios para Agitadores
- Benchmark Accesorios para Agitadores
- N-Biotek Accesorios para Agitadores
- Biosan Accesorios para Agitadores
- Labnet Int. Accesorios para Agitadores
- Vórtex
- Analisis Imagen, animales, plantas, geles
- Balanzas
- Baños Termostáticos
- Cabinas Flujo / Extraccion gases / PCR
- Centrifugas
- Detectores de Radioactividad
- Electroforesis
- Electroquímica
- Equipos Microplacas
- Espectrofotometros
- Experimentacion Animal
- Hornos de Hibridacion
- Homogeneizadores
- Estufas / Equipos calor, frio
- Luminómetros de Tubos
- Microbiologia
- Pipetas / Dispensadores
- Pipetas Labnet Int. Monocanales Automaticos
- Pipetas HTL Monocanales Automáticas
- Pipeta Accumax Mono y Multicanales
- Pipetas Labnet Int. Multicanales
- Pipetas HTL Multicanales
- Pipetas Volumen Fijo
- Pipetas Electrónicas
- Dispensadores
- Dispensadores de Botella
- Pipetas Biosan Monocanales
- Pipetas Biosan Multicanales
- PCR / Tiempo Real (qPCR)l / Cicladores
- QPCR, Sistemas automaticos
- Sonicadores / Ultrasonidos
- Ultracongeladores
- Bombas Jeringa / Vacio / Osmoticas
- Ultracentrífugas
- Micro Array label free
- Contadores de Células
- Contenedores Criogenicos
- Producción agua ultrapura
- Electrospinning
- Agitadores / Agit. Incubadores
- Reactivos
- Consumibles
- Catálogos PDF
Listado de productos por fabricante AbMole
TNO155
TNO155 is a first-in-class, selective, orally active wild-type SHP2 metamorphosis inhibitor with an IC50 value of 0.011 µM. tNO155 has good water solubility (0.736 mM), moderate lipophilicity (LogP=1.6), high lipophilic efficiency (>6), and no hERG inhibition (IC50 >30 μM) and no phototoxicity. Does not inhibit CYP450.
TNO155
TNO155 is a first-in-class, selective, orally active wild-type SHP2 metamorphosis inhibitor with an IC50 value of 0.011 µM. tNO155 has good water solubility (0.736 mM), moderate lipophilicity (LogP=1.6), high lipophilic efficiency (>6), and no hERG inhibition (IC50 >30 μM) and no phototoxicity. Does not inhibit CYP450.
TNO155
TNO155 is a first-in-class, selective, orally active wild-type SHP2 metamorphosis inhibitor with an IC50 value of 0.011 µM. tNO155 has good water solubility (0.736 mM), moderate lipophilicity (LogP=1.6), high lipophilic efficiency (>6), and no hERG inhibition (IC50 >30 μM) and no phototoxicity. Does not inhibit CYP450.
TNP-470
TNP-470 (AGM-1470; NSC 642492) is a synthetic analog of fumagillin (or Fumagillol) and a methionine aminopeptidase-2 inhibitor.
Tobramycin
Tobramycin is an aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius.
Tobramycin
Tobramycin is an aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius.
Tobramycin
Tobramycin is an aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius.
Tobramycin sulfate
Tobramycin sulfate (Nebramycin Factor 6 sulfate) is a parenterally administered, broad spectrum aminoglycoside antibiotic that is widely used in the treatment of moderate to severe bacterial infections due to sensitive organisms.
Toceranib
Toceranib(SU 11654; PHA 291639) is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFRβ.
Toceranib
Toceranib(SU 11654; PHA 291639) is a kinase inhibitor with both antitumor and antiangiogenic activity through inhibition of KIT, vascular endothelial growth factor receptor 2, and PDGFRβ.
Tocilizumab
Tocilizumab is a humanized monoclonal antibody that binds to the interleukin-6 receptor. Tocilizumab prevents binding of IL-6 to the IL-6R, thereby inhibiting both classic and trans-signaling. Tocilizumab can be used for the research of rheumatoid arthritis and COVID-19.
Toddaculin
Toddaculin